Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Vero

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Minerva Medica|July 3, 2009
[The treatment of hepatocellular carcinoma: an update]V Vero, S Racco, M Biolato, et al.
European Review for Medical and Pharmacological Sciences|October 22, 2005
Fatty liver and drugsA Grieco, A Forgione, L Miele, et al.
European Review for Medical and Pharmacological Sciences|October 20, 2005
Nonalcoholic fatty liver disease: defining a common problemG Gasbarrini, V Vero, L Miele, et al.
European Review for Medical and Pharmacological Sciences|October 20, 2005
Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH)E Capristo, L Miele, A Forgione, et al.
European Review for Medical and Pharmacological Sciences|October 20, 2005
The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitisL Miele, A Forgione, A P Hernandez, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Minerva Medica|July 3, 2009
[The treatment of hepatocellular carcinoma: an update]V Vero, S Racco, M Biolato, et al.
European Review for Medical and Pharmacological Sciences|October 22, 2005
Fatty liver and drugsA Grieco, A Forgione, L Miele, et al.
European Review for Medical and Pharmacological Sciences|October 20, 2005
Nonalcoholic fatty liver disease: defining a common problemG Gasbarrini, V Vero, L Miele, et al.
European Review for Medical and Pharmacological Sciences|October 20, 2005
Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH)E Capristo, L Miele, A Forgione, et al.
European Review for Medical and Pharmacological Sciences|October 20, 2005
The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitisL Miele, A Forgione, A P Hernandez, et al.
Pageof 1